VENT-AVOID Trial: Avoiding Acute Hypercapnic Respiratory Failure!
- PMID: 38608272
- PMCID: PMC11208963
- DOI: 10.1164/rccm.202403-0514LE
VENT-AVOID Trial: Avoiding Acute Hypercapnic Respiratory Failure!
Comment in
-
Reply to Tiruvoipati et al.: VENT-AVOID Trial: Avoiding Acute Hypercapnic Respiratory Failure!Am J Respir Crit Care Med. 2024 Jun 15;209(12):1515. doi: 10.1164/rccm.202403-0618LE. Am J Respir Crit Care Med. 2024. PMID: 38608271 Free PMC article. No abstract available.
Comment on
-
Extracorporeal Carbon Dioxide Removal to Avoid Invasive Ventilation During Exacerbations of Chronic Obstructive Pulmonary Disease: VENT-AVOID Trial - A Randomized Clinical Trial.Am J Respir Crit Care Med. 2024 Mar 1;209(5):529-542. doi: 10.1164/rccm.202311-2060OC. Am J Respir Crit Care Med. 2024. PMID: 38261630 Clinical Trial.
References
-
- Duggal A, Conrad SA, Barrett NA, Saad M, Cheema T, Pannu S, et al. VENT-AVOID Investigators Extracorporeal carbon dioxide removal to avoid invasive ventilation during exacerbations of chronic obstructive pulmonary disease: VENT-AVOID trial—a randomized clinical trial. Am J Respir Crit Care Med . 2024;209:529–542. - PubMed
-
- Braune S, Sieweke A, Brettner F, Staudinger T, Joannidis M, Verbrugge S, et al. The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med . 2016;42:1437–1444. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical